EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58

Richard Kanyo iD, Shawn M Lamothe iD, Thomas M Hammond, Harley T Kurata iD

British Journal of Pharmacology · 2026-01 · 183 (2) · 333-348

DOI: 10.1111/bph.70186 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2025-09-12. Written by Richard Kanyo and 3 co-authors. Institution: Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. Major MEDLINE topics: KCNQ2 Potassium Channel. Cited 5 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: CIHR, Canadian Institutes of Health Research postdoctoral fellowship, Alberta Innovates Summer Research Studentship.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose K V 7(KCNQ) potassium channels are key modulators of neuronal excitability, and promising targets for development of drugs for epilepsy and pain. We investigated a candidate K V 7 drug, QO‐58, which has been previously described but has an unclear mechanism of action. Experimental Approach Targeted mutations or chimeric rearrangements of K V 7 channels were used to investigate potential sites of drug binding. K V 7 channels were expressed in Xenopus oocytes or HEK cells for electrophysiology and pharmacological characterisation. Key Results QO‐58 shares characteristic features of other voltage sensor domain (VSD)‐targeted potentiators. These include subtype specificity for K V 7.2 over K V 7.3, prominent state‐dependent actions, and marked deceleration of closure of K V 7.2. VSD mutations influence the actions of QO‐58 and another VSD‐targeted drug, ICA‐069673. Interestingly, K V 7.2[F168L] mutation, previously shown to abolish ICA‐069673 sensitivity, does not weaken QO‐58 actions. However, K V 7.2[F168W] reduces QO‐58 effects, while preserving sensitivity to ICA‐069673. This finding indicates subtle differences in the interaction of these drugs with the VSD binding site. Conclusions and Implications Key contacts underlying sensitivity to VSD‐targeted potentiators may vary significantly depending on the chemical and steric features of the drug. We anticipate that further investigation of VSD‐targeted drugs will continue to clarify the complex pharmacophore of the VSD binding pocket in K V 7 channels.

Subjects

MeSH terms (MEDLINE)

KCNQ2 Potassium ChannelHumansHEK293 CellsAnimalsXenopus laevisOocytesMutationKCNQ3 Potassium ChannelPhenylenediamines

Author keywords

KCNQKv7QO‐58pharmacologyporepotassium channelvoltage sensor

Substances

KCNQ2 Potassium ChannelKCNQ3 Potassium ChannelPhenylenediamines

Authors and institutions

  • Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.

ORCID profiles: Richard Kanyo, Shawn M Lamothe, Harley T Kurata

Funding

  • CIHR
  • Canadian Institutes of Health Research postdoctoral fellowship
  • Alberta Innovates Summer Research Studentship

Cite

APA

Kanyo, R., Lamothe, S. M., Hammond, T. M., & Kurata, H. T. (2026). State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58. British Journal of Pharmacology, 183(2), 333-348. https://doi.org/10.1111/bph.70186

Vancouver

Kanyo R, Lamothe SM, Hammond TM, Kurata HT. State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58. British Journal of Pharmacology. 2026;183(2):333-348. doi:10.1111/bph.70186

BibTeX
@article{Kanyo2026,
  author = {Kanyo, Richard and Lamothe, Shawn M and Hammond, Thomas M and Kurata, Harley T},
  title = {State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {2},
  pages = {333--348},
  doi = {10.1111/bph.70186}
}
Start for free →